EPAM
EPAM Systems, Inc.
EPAM's fundamentals are strong and it looks cheap: trading at 21x earnings, below its usual 37x. Analysts expect earnings growth.
EPAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
EPAM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
EPAM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $164 | — |
| Current | 21x | $164 | — |
| Cheap | 24x | $188 | +15% |
| Fair | 36x | $291 | +78% |
| Expensive | 65x | $517 | +216% |
Historical ranges are pointers, not guarantees.
EPAM's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
EPAM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect EPAM's earnings to grow and its profitability to improve, with its revenue holding steady.
EPAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.10 | +76% |
| Q3 2026 | $7.99 | +22% |
| Q2 2026 | $7.37 | +5.1% |
| Q1 2026 | $6.96 | -2.7% |
| Q4 2025 | $6.72 | -14% |
| Q3 2025 | $6.55 | -15% |
| Q2 2025 | $7.01 | +0.6% |
| Q1 2025 | $7.15 | -2.1% |
| Q4 2024 | $7.84 | +11% |
EPAM earned $7.99 per share over the past year, up 22% from the year before.
EPAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +2.3% |
| Q2 2026 | $1.4B | +4.5% |
| Q1 2026 | $1.4B | +7.6% |
| Q4 2025 | $1.4B | +13% |
| Q3 2025 | $1.4B | +19% |
| Q2 2025 | $1.4B | +18% |
| Q1 2025 | $1.3B | +12% |
| Q4 2024 | $1.2B | +7.9% |
EPAM's revenue has grown year over year for nine quarters in a row: $1.4B last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +1.9 points |
| Q2 2026 | 11% | +1.4 points |
| Q1 2026 | 8.3% | +0.7 points |
| Q4 2025 | 11% | -0.3 points |
| Q3 2025 | 10% | -4.8 points |
| Q2 2025 | 9.3% | -1.2 points |
| Q1 2025 | 7.6% | -1.9 points |
| Q4 2024 | 11% | +0.4 points |
EPAM's operating margin was 12% last quarter, up 1.9 points from the same quarter a year ago.
EPAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $274.2M | -4.3% |
| Q2 2026 | -$17.6M | -141% |
| Q1 2026 | -$54.2M | -466% |
| Q4 2025 | $268.1M | +134% |
| Q3 2025 | $286.4M | +21% |
| Q2 2025 | $43.4M | -17% |
| Q1 2025 | $14.8M | -88% |
| Q4 2024 | $114.5M | -29% |
EPAM generated $470M in free cash flow over the past year, up 2.5% from the year before.
EPAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -798K shares |
| 1 year | -7.8% | -4.3M shares |
| 3 years | -13% | -7.5M shares |
| 5 years | -13% | -7.7M shares |
| Available history | -11% | -6.2M shares |
EPAM has 51M diluted shares, down 7.8% from a year ago, with $712M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $79.9M |
| Q2 2026 | $85M |
| Q1 2026 | $324M |
| Q4 2025 | $223.5M |
| Q3 2025 | $82.1M |
| Q2 2025 | $196.5M |
| Q1 2025 | $160M |
| Q4 2024 | $13M |
EPAM spent $712M buying back its own shares over the past year, up 58% from the year before.
EPAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -2.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
EPAM has more cash than debt.
EPAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.8 | Overbought |
| Stochastic | 93.9 | Overbought |
EPAM's weekly RSI is 72 (overbought) and its Stochastic is 94 (overbought).
EPAM PE vs Technology Sector
| Metric | EPAM | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 26% below |
| PE % | 11 | 35 | 24 pts below |
EPAM is trading at 21x earnings, a 26% discount to the Technology sector's median of 28x.
EPAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $131.5 | 25% above |
| 20 week MA | $114.0 | 44% above |
| 50 week MA | $134.5 | 22% above |
| 100 week MA | $158.5 | 3.3% above |
| 200 week MA | $203.6 | 20% below |
EPAM has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 20% below its 200-week average.
EPAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $214.4 | $356.3 | +66% |
| 2021 | $356.3 | $663.1 | +86% |
| 2022 | $663.1 | $323.7 | -51% |
| 2023 | $323.7 | $297.3 | -8.1% |
| 2024 | $297.3 | $238.5 | -20% |
| 2025 | $238.5 | $211.4 | -11% |
| 2026 YTD | $211.4 | $163.8 | -23% |
EPAM has finished four years in a row lower, and it's down 23% so far in 2026.